Bill > S3452

This bill, titled the Biological Intellectual Property Protection Act of 2025, aims to safeguard sensitive United States biotechnology information by requiring a license for the export of digital sequences of synthetic DNA or RNA to "foreign entities of concern." A "foreign entity of concern" is defined as a government entity, an individual, or an organization that is subject to the jurisdiction of, or is owned, directed, or controlled by, a "foreign country of concern," which is understood to be a nation that poses a threat to U.S. national security. The bill specifically targets synthetic DNA or RNA molecules that are constructed, synthesized, or modified, and can replicate in living cells, recognizing that such genetic sequences can reveal critical research and development insights. This measure is proposed in response to concerns that countries like the People's Republic of China, through their military-civil fusion strategy and national security laws, systematically seek to acquire U.S. intellectual property and sensitive data to advance their military and technological capabilities, thereby posing a direct threat to U.S. national security. The bill amends the Export Control Reform Act of 2018 to implement this new licensing requirement, with an exception for information already covered by existing export regulations.

Housing and Urban Affairs

https://www.congress.gov/bill/119th-congress/senate-bill/3452/all-info